You are here

  • Home
  • Archive
  • Volume 99, Issue 7
  • A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1

Citation Tools

Article menu
Download PDFPDF
Clinical science
A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Narayanan R, Panchal B, Das T on behalf of MARVEL study group, et al
A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1
British Journal of Ophthalmology 2015;99:954-959.